Articles

A-103 VALIDATION OF A CHROMOGENIC ASSAY FOR FVIII: C AND FIX: C (CSA) MEASURING AND COMPARISON WITH A CHRONOMETRIC ASSAY (OSA)

BJH - volume 8, issue Abstract Book BSTH, february 2017

C. Haeseleer , A. Demulder MD, PhD, P.-Q. Le , A. Hunanyan , A. Ferster MD, PhD, L. Rozen PharmD

Read more

Endogenous thrombin generation potential: an added value parameter to individualize prophylaxis treatment in pediatric haemophiliac patients?

BJH - 2014, issue Abstract Book BSTH, november 2014

E. Pizzuti , L. Rozen PharmD, P.-Q. Le , A. Ferster MD, PhD, A. Demulder MD, PhD

Read more

P.51 Relationship between thrombin generation and blood flow velocity in large cerebral arteries of children with sickle cell disease

BJH - 2013, issue BHS Abstractbook, january 2013

D. Noubouossie MD, F. Ziereisen , P.-Q. Le , D. Willems , B. Mahadeb , L. Rozen PharmD, M. Ngalula Mujinga , A. Demulder MD, PhD, A. Ferster MD, PhD

Read more

P.52 Newborn screening for Sickle Cell Disease in Brussels, a program with an ongoing clinical outcome improvement

BJH - 2013, issue BHS Abstractbook, january 2013

P.-Q. Le , B. Gulbis MD, PhD, L. Dedeken , C. Heijmans , A. Vanderfaeillie MD, C. Vermylen , S. Huybrechts MD, C. Devalck , F. Cotton , B.C. Nguyen , F. Vertongen , M. Ngalula , A. Ferster MD, PhD

Read more